ALDX
Aldeyra Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:B-
Company Profile
CEO
Todd C. Brady
IPO Date
2014-05-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Aldeyra Therapeutics, Inc.
CEO
Todd C. Brady
IPO Date
2014-05-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US